Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents
NCT00795951Phase 4Completed
- Sponsor
- Allerderm Laboratories, Inc.
- Start
- Nov 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ethylenediamine dihydrochloride in allergic contact dermatitis (ACD), sponsored by Allerderm Laboratories, Inc. Primary endpoint: Positive Reactions to Allergens and Negative Control at 7 days. Started Nov 2008; status: completed.
02
Drugs
ethylenediamine dihydrochloride
03
Conditions
allergic contact dermatitis (ACD)
Beyond the preview
Go deeper on NCT00795951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795951.